INMD - צמיחת הכנסות ב-12 חודשים נגררים InMode MD

InMode Ltd. (INMD) demonstrates financial resilience due to its lack of debt and high margins from the sale of consumables. The 12-month YoY sales change chart on the GURU.Markets website contains this chart, where 2.40 expresses the latest level of the metric. Revenues are based on consumer demand and licensing, while the development of RF technologies in ophthalmology and gynecology ensures the company's technological leadership.

InMode Ltd. is scaling its business through high-margin proprietary radiofrequency lipolysis systems that minimize operating expenses. An analysis of LTM sales dynamics year-over-year allows for tracking the actual growth rate of trailing twelve-month revenue, comparing official GAAP data with market consensus to identify hidden risks of declining demand for minimally invasive procedures in aesthetic medicine.